Literature DB >> 33187763

Epidemiological distribution of hepatitis B virus genotypes in 1-29-year-olds in the mainland of China.

Qiu-Dong Su1, Shuang Zhang1, Feng Wang1, He Liu1, Guo-Min Zhang2, Hui Zheng2, Feng Qiu1, Xiao-Jin Sun2, Xiao-Feng Liang2, Sheng-Li Bi1, Li-Ping Shen3, Fu-Zhen Wang2.   

Abstract

BACKGROUND: To analyze the epidemiological distribution of Hepatitis B virus (HBV) genotype in the mainland of China following the implementation of effective preventive measures.
METHODS: Five hundred and seventeen HBsAg-positive subjects aged 1-29 years surveyed in the 2014 national HBV sero-survey in the mainland of China were enrolled in the study. The full-length HBV genome was obtained by PCR amplification and sequencing. The HBV genotype was determined by phylogenetic analysis. Combined with questionnaire information, HBV genotype distribution was analyzed.
RESULTS: Of the 517 HBsAg-positive subjects, 369 (71.4%) were included in the analysis. HBV genotypes found were B (45.0%), C (36.6%), D (6.0%), C/D (9.8%), B/C (2.2%), and I (0.5%). Geographic differences in HBV genotype were significant for seven regions. Three serotypes were found: adw (47.2%), adr (35.5%), and ayw (17.3%). B2 (43.9%) and C2 (25.2%) were the two major subgenotypes. The predominant genotypes differed between the Han group and the other ethnic groups. No statistical differences in genotype distribution were found by gender, age group, or hepatitis B (HepB) vaccination history.
CONCLUSION: The prevalence of HBV genotype B was higher than that of genotype C with subgenotypes B2 and C2 endemic in 1-29-year-olds in the mainland of China, after HBV prevalence has reduced significantly due to the implementation of preventive measures. HepB vaccination or other factors did not interfere with HBV genotype distribution. The surveillance of HBV genotype was essential for responding to the potential changes and impact on the preventive policies in the future.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  China; Genotype distribution; Hepatitis B virus

Mesh:

Substances:

Year:  2020        PMID: 33187763     DOI: 10.1016/j.vaccine.2020.09.083

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  Association between viral infection other than human papillomavirus and risk of esophageal carcinoma: a comprehensive meta-analysis of epidemiological studies.

Authors:  Hui Geng; Yaqi Xing; Jingbing Zhang; Kexin Cao; Meijie Ye; Geng Wang; Caixia Liu
Journal:  Arch Virol       Date:  2021-10-12       Impact factor: 2.574

2.  HBV induces liver fibrosis via the TGF-β1/miR-21-5p pathway.

Authors:  Wenting Li; Xiaolan Yu; Xiliu Chen; Zheng Wang; Ming Yin; Zonghao Zhao; Chuanwu Zhu
Journal:  Exp Ther Med       Date:  2020-12-25       Impact factor: 2.447

3.  Molecular Epidemiological Characteristics and Risk Factors for Acquiring HBV Among Li Ethnic in Baisha County, Hainan Island-Subgenotype D3 Was First Discovered in China.

Authors:  Ru Xu; Dandan Song; Min Wang; Jieting Huang; Qiao Liao; Zhengang Shan; Xia Rong; Yongshui Fu
Journal:  Front Microbiol       Date:  2022-02-07       Impact factor: 5.640

4.  Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients.

Authors:  Minghui Li; Fangfang Sun; Xiaoyue Bi; Yanjie Lin; Liu Yang; Yao Lu; Lu Zhang; Gang Wan; Wei Yi; Linqing Zhao; Yao Xie
Journal:  Virol Sin       Date:  2022-03-04       Impact factor: 6.947

5.  Correlation Analysis of Breast and Thyroid Nodules: A Cross-Sectional Study.

Authors:  Jingtai Chen; Zhou Xu; Lingmi Hou; Yunhui Tang; Shuangqiang Qian; Hongyu Pu; Juan Tang; Yanchun Gao
Journal:  Int J Gen Med       Date:  2021-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.